Pharmabiz

Lupin receives EIR from US FDA for its Nagpur injectable facility

Lupin receives EIR from US FDA for its Nagpur injectable facility: Our Bureau, Mumbai Wednesday, December 17, 2025, 13:40 Hrs [IST] Global pharma major Lupin Limited (Lupin) annou ...
Pharmabiz

ALZpath & Siemens Healthineers ink licensing agreement to advance global access to blood-based Alzheimer’s disease diagnostic testing

ALZpath & Siemens Healthineers ink licensing agreement to advance global access to blood-based Alzheimer’s disease diagnostic testing: Carlsbad, California Wednesday, December 1 ...
Pharmabiz

Litemed backed CURAPOD gets CDSCO nod, a wearable class II device for musculoskeletal pain

Litemed backed CURAPOD gets CDSCO nod, a wearable class II device for musculoskeletal pain: Our Bureau, Bengaluru Wednesday, December 17, 2025, 14:30 Hrs [IST] CURAPOD, a Made-in- ...
Pharmabiz

EMA committee recommends marketing approval for Lupin’s biosimilar ranibizumab

EMA committee recommends marketing approval for Lupin’s biosimilar ranibizumab: Our Bureau, Mumbai Wednesday, December 17, 2025, 14:40 Hrs [IST] Global pharma major Lupin Limite ...
Pharmabiz

Lindus Health and Quotient Sciences partner to speed up drug development from first-in-human to pivotal trials

Lindus Health and Quotient Sciences partner to speed up drug development from first-in-human to pivotal trials: Boston Wednesday, December 17, 2025, 17:00 Hrs [IST] Lindus Health, ...
Pharmabiz

Glenmark enters collaboration and distribution agreement with Jiangsu Hansoh Pharma for Aumolertinib, a third-generation GFR-TKI to treat NSCLC

Glenmark enters collaboration and distribution agreement with Jiangsu Hansoh Pharma for Aumolertinib, a third-generation GFR-TKI to treat NSCLC: Our Bureau, Mumbai Wednesday, Dece ...
Pharmabiz

Lipocine's PPD phase 3 study oral brexanolone hits 80% enrollment milestone

Lipocine's PPD phase 3 study oral brexanolone hits 80% enrollment milestone: Salt Lake City Wednesday, December 17, 2025, 18:00 Hrs [IST] Lipocine Inc., a biopharmaceutical compan ...
Pharmabiz

US FDA approves AstraZeneca and Daiichi Sankyo’s Enhertu plus pertuzumab for 1st-line treatment of patients with HER2-positive metastatic breast cancer

US FDA approves AstraZeneca and Daiichi Sankyo’s Enhertu plus pertuzumab for 1st-line treatment of patients with HER2-positive metastatic breast cancer: Cambridge, UK Wednesday, ...
Pharmabiz

Arth by Emcure and Jai Vakeel Foundation host event to honour and support neurodivergent community

Arth by Emcure and Jai Vakeel Foundation host event to honour and support neurodivergent community: Our Bureau, Mumbai Wednesday, December 17, 2025, 17:20 Hrs [IST] Arth by Emcure ...
Pharmabiz

Utah Cancer Specialists partners with Canopy for remote therapeutic monitoring and Enterprise AI

Utah Cancer Specialists partners with Canopy for remote therapeutic monitoring and Enterprise AI: New York Wednesday, December 17, 2025, 16:00 Hrs [IST] Canopy, the leader in Ente ...
Pharmabiz

Johnson & Johnson’s sNDA for Akeega gets US FDA approval to treat patients with BRCA2-mutated mCSPC

Johnson & Johnson’s sNDA for Akeega gets US FDA approval to treat patients with BRCA2-mutated mCSPC: Horsham, Pennsylvania Wednesday, December 17, 2025, 13:00 Hrs [IST] Johnson ...
Pharmabiz

Decode Age raises Rs. 14.48 crore in Pre Series A funding to advance longevity science and gut microbiome research

Decode Age, a longevity science organisation focused on ageing biology, biomarker research and gut microbiome science, has raised Rs. 14.48 crore in its Pre Series A funding round led by Dr Krishna ...